GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort.
- DOI
- 10.1016/j.ebiom.2024.105076
- Published
- 2024 Apr
- Container
- EBioMedicine
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- supportingDirectory of Open Access Journals: A matching record was returned by DOAJ.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.ebiom.2024.105076,
title = {GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort.},
author = {Pellerin D and Heindl F and Wilke C and Danzi MC and Traschütz A and Ashton C and Dicaire MJ and Cuillerier A and Del Gobbo G and Boycott KM and Claassen J and Rujescu D and Hartmann AM and Zuchner S and Brais B and Strupp M and Synofzik M},
year = {2024},
journal = {EBioMedicine},
doi = {10.1016/j.ebiom.2024.105076},
url = {https://doi.org/10.1016/j.ebiom.2024.105076}
}RIS
TY - JOUR TI - GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort. AU - Pellerin D AU - Heindl F AU - Wilke C AU - Danzi MC AU - Traschütz A AU - Ashton C AU - Dicaire MJ AU - Cuillerier A AU - Del Gobbo G AU - Boycott KM AU - Claassen J AU - Rujescu D AU - Hartmann AM AU - Zuchner S AU - Brais B AU - Strupp M AU - Synofzik M PY - 2024 JO - EBioMedicine DO - 10.1016/j.ebiom.2024.105076 UR - https://doi.org/10.1016/j.ebiom.2024.105076 ER -
APA
D, P., F, H., C, W., MC, D., A, T., C, A., MJ, D., A, C., G, D. G., KM, B., J, C., D, R., AM, H., S, Z., B, B., M, S., & M, S. (2024). GAA-FGF14 disease: defining its frequency, molecular basis, and 4-aminopyridine response in a large downbeat nystagmus cohort.. EBioMedicine. https://doi.org/10.1016/j.ebiom.2024.105076
Source records
- pubmed · retrieved 2026-09-27T07:49:08.360Z
- europe-pmc · retrieved 2026-09-27T07:49:08.362Z
- doaj · retrieved 2026-09-27T07:49:08.369Z